Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Blood|January 29, 2015
Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injuryYe Tian, Breia Salsbery, Min Wang, et al.
Blood|November 11, 2015
High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesionDominic W Chung, Junmei Chen, Minhua Ling, et al.
International Journal of Hematology|May 28, 2017
Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populationsKeiji Nogami, Midori Shima, Katsuyuki Fukutake, et al.
International Journal of Hematology|November 18, 2017
Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populationsKeiji Nogami, Midori Shima, Katsuyuki Fukutake, et al.
Research and Practice in Thrombosis and Haemostasis|June 12, 2025
Exploration of biomarkers for inhibitor development in persons with hemophilia AMeng-Ni Fan, Tangliang Shen, Barbara A Konkle, et al.
The New England Journal of Medicine|September 9, 2020
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia ABarbara A Konkle, Amy D Shapiro, Doris V Quon, et al.
American Journal of Obstetrics and Gynecology|June 2, 2009
Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panelAndra H James, Peter A Kouides, Rezan Abdul-Kadir, et al.
Journal of Thrombosis and Haemostasis : JTH|August 13, 2023
Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community studyWei Liu, Kavita Patel, Yi Wang, et al.
Transfusion|September 12, 2021
How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership?Maureen J Miller, Adam Skrzekut, Ian Kracalik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 1, 2020
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension studyBeatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, et al.
Pageof 11